Vaccines & Disease · Influenza

Swine Flu Vaccines

1 min read

Swine flu vaccines are being developed and will be tested by pharmaceutical companies and U.S. federal health agencies for release to Americans in the fall of 2009. As of July 23, 2009, FDA and CDC officials are discussing difficulties with H1N1 virus strain selection and production. Some have suggested that two doses of the vaccine given several weeks apart will be needed to confer protection.

An inactivated, injectable swine flu vaccine is being created by Novartis, Sanofi Pasteur and GlaxoSmithKline and a live attenuated virus nasal spray vaccine is being created by MedImmune. A limited supply (about 60 to 80 million doses) may be available in September or mid-October. The government reportedly has contracted with vaccine manufacturers to produce a total of 193 million doses of swine flu vaccine (and also has ordered 119 million doses of MF-59 and AS03 adjuvant).

Below are topics with additional information about H1N1 2009 swine flu vaccine.

Select disease / vaccine